Literature DB >> 30590480

Drug Use and Postoperative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-analysis.

Ryan Hall1, Michael Shaughnessy1, Griffin Boll2, Kenneth Warner2, Helen W Boucher1,3, Raveendhara R Bannuru4, Alysse G Wurcel3,5.   

Abstract

BACKGROUND: Infective endocarditis (IE) often requires surgical intervention. An increasingly common cause of IE is injection drug use (IDU-IE). There is conflicting evidence on whether postoperative mortality differs between people with IDU-IE and people with IE from etiologies other than injection drug use (non-IDU-IE). In this manuscript, we compare short-term postoperative mortality in IDU-IE vs non-IDU-IE through systematic review and meta-analysis.
METHODS: The review was conducted according to the Cochrane Handbook for Systematic Reviews of Interventions and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Publication databases were queried for key terms included in articles up to September 2017. Randomized controlled trials, prospective cohorts, or retrospective cohorts that reported on 30-day mortality or in-hospital/operative mortality following valve surgery and that compared outcomes between IDU-IE and non-IDU-IE were included.
RESULTS: Thirteen studies with 1593 patients (n = 341 [21.4%] IDU-IE) were included in the meta-analysis. IDU-IE patients more frequently had tricuspid valve infection, Staphylococcus infection, and heart failure before surgery. Meta-analysis revealed no statistically significant difference in 30-day postsurgical mortality or in-hospital mortality between the 2 groups.
CONCLUSIONS: Despite differing preoperative clinical characteristics, early postoperative mortality does not differ between IDU-IE and non-IDU-IE patients who undergo valve surgery. Future research on long-term outcomes following valve replacement is needed to identify opportunities for improved healthcare delivery with IDU-IE. Published by Oxford University Press for the Infectious Diseases Society of America 2018.

Entities:  

Keywords:  endocarditis; injection drug use; postoperative mortality; valve surgery

Year:  2019        PMID: 30590480      PMCID: PMC6743840          DOI: 10.1093/cid/ciy1064

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  46 in total

Review 1.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

2.  [Survival of patients with infectious endocarditis in various treatment methods].

Authors:  G G Khubulava; S V Maslov; T V Ktsoeva; Iu R Kovalev
Journal:  Klin Med (Mosk)       Date:  2004

3.  Long-term outcomes in valve replacement surgery for infective endocarditis.

Authors:  Scott P Kaiser; Spencer J Melby; Andreas Zierer; Richard B Schuessler; Marc R Moon; Nader Moazami; Michael K Pasque; Charles Huddleston; Ralph J Damiano; Jennifer S Lawton
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

4.  Infective endocarditis of native cardiac valves: 22 years' surgical experience.

Authors:  M Cotrufo; A Carozza; G Romano; M De Feo; A Della Corte
Journal:  J Heart Valve Dis       Date:  2001-07

5.  Staphylococcus aureus endocarditis: a consequence of medical progress.

Authors:  Vance G Fowler; Jose M Miro; Bruno Hoen; Christopher H Cabell; Elias Abrutyn; Ethan Rubinstein; G Ralph Corey; Denis Spelman; Suzanne F Bradley; Bruno Barsic; Paul A Pappas; Kevin J Anstrom; Dannah Wray; Claudio Q Fortes; Ignasi Anguera; Eugene Athan; Philip Jones; Jan T M van der Meer; Tom S J Elliott; Donald P Levine; Arnold S Bayer
Journal:  JAMA       Date:  2005-06-22       Impact factor: 56.272

6.  Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment.

Authors:  Antonio Carozza; Luca Salvatore De Santo; Gianpaolo Romano; Alessandro Della Corte; Fabio Ursomando; Michelangelo Scardone; Giuseppe Caianiello; Maurizio Cotrufo
Journal:  J Heart Valve Dis       Date:  2006-01

7.  In-hospital and long-term mortality in infective endocarditis in injecting drug users compared to non-drug users: a retrospective study of 192 episodes.

Authors:  Anders Thalme; Katarina Westling; Inger Julander
Journal:  Scand J Infect Dis       Date:  2007

8.  Mortality from infective endocarditis: clinical predictors of outcome.

Authors:  S M Wallace; B I Walton; R K Kharbanda; R Hardy; A P Wilson; R H Swanton
Journal:  Heart       Date:  2002-07       Impact factor: 5.994

9.  Cardiac valve replacement in human immunodeficiency virus-infected patients.

Authors:  Tec Chong; Diane E Alejo; Peter S Greene; J Mark Redmond; Marc S Sussman; William A Baumgartner; Duke E Cameron
Journal:  Ann Thorac Surg       Date:  2003-08       Impact factor: 4.330

10.  [Surgical treatment of right-sided infective endocarditis].

Authors:  J J Pagbe; T Mesana; A Goudard; D Blin; R Gulino; A Cornen; A Mouly-Bandini; J R Monties
Journal:  Presse Med       Date:  1991-06-22       Impact factor: 1.228

View more
  12 in total

1.  Risk of reoperative valve surgery for endocarditis associated with drug use.

Authors:  Makoto Mori; Syed Usman Bin Mahmood; Asher J Schranz; Ibrahim Sultan; Andrea L Axtell; Nadeen Sarsour; William Hiesinger; Marko T Boskovski; Sameer Hirji; Tsuyoshi Kaneko; Joseph Woo; Paul Tang; Arminder S Jassar; Pavan Atluri; Bryan A Whitson; Thomas Gleason; Arnar Geirsson
Journal:  J Thorac Cardiovasc Surg       Date:  2019-07-10       Impact factor: 5.209

2.  A Wake-Up Call: Outcomes Following Infective Endocarditis in Persons Who Inject Drugs.

Authors:  Asher J Schranz
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

3.  The Evolving Burden of Drug Use Associated Infective Endocarditis in the United States.

Authors:  Arnar Geirsson; Asher Schranz; Oliver Jawitz; Makoto Mori; Liqi Feng; Brittany A Zwischenberger; Alexander Iribarne; Joseph Dearani; Gregory Rushing; Vinay Badhwar; Juan A Crestanello
Journal:  Ann Thorac Surg       Date:  2020-05-06       Impact factor: 4.330

4.  Impact of Substance Use Disorder on Midterm Mortality After Valve Surgery for Endocarditis.

Authors:  Alysse G Wurcel; Griffin Boll; Deirdre Burke; Rani Khetarpal; Patrick J Warner; Alice M Tang; Kenneth G Warner
Journal:  Ann Thorac Surg       Date:  2019-10-17       Impact factor: 4.330

5.  The Opioid Crisis and the Inpatient Floor: Considering Injection Drug Use in the Management of Infective Endocarditis and Acute Pain.

Authors:  Lauren M Mitchell; Aimee Milliken; Mary W Montgomery; Steve K Singh; Joji Suzuki
Journal:  Harv Rev Psychiatry       Date:  2020 Sep/Oct       Impact factor: 3.732

6.  Expanding the Team: Optimizing the Multidisciplinary Management of Drug Use-Associated Infective Endocarditis.

Authors:  Matthew O'Donnell; Honora Englander; Luke Strnad; Castigliano M Bhamidipati; Evan Shalen; Patricio A Riquelme
Journal:  J Gen Intern Med       Date:  2022-01-11       Impact factor: 5.128

7.  Surgical treatment of infective endocarditis: Results in 831 patients from a single center.

Authors:  Arman Kilic; Lauren V Huckaby; Yeahwa Hong; Ibrahim Sultan; Edgar Aranda-Michel; Floyd Thoma; Yisi Wang; Forozan Navid; Thomas G Gleason
Journal:  J Card Surg       Date:  2020-08-25       Impact factor: 1.778

Review 8.  Infective Endocarditis in Persons Who Use Drugs: Epidemiology, Current Management, and Emerging Treatments.

Authors:  Asher Schranz; Joshua A Barocas
Journal:  Infect Dis Clin North Am       Date:  2020-09       Impact factor: 5.982

9.  Effect of Publicly Reported Aortic Valve Surgery Outcomes on Valve Surgery in Injection Drug- and Non-Injection Drug-Associated Endocarditis.

Authors:  Simeon D Kimmel; Alexander Y Walley; Benjamin P Linas; Bindu Kalesan; Eric Awtry; Nikola Dobrilovic; Laura White; Marc LaRochelle
Journal:  Clin Infect Dis       Date:  2020-07-27       Impact factor: 9.079

10.  High Morbidity and Mortality Among Patients With Sentinel Admission for Injection Drug Use-Related Infective Endocarditis.

Authors:  P Alexander Leahey; Mary T LaSalvia; Elana S Rosenthal; Adolf W Karchmer; Christopher F Rowley
Journal:  Open Forum Infect Dis       Date:  2019-03-01       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.